Habig Scott Michael 4
4 · Aurinia Pharmaceuticals Inc. · Filed Feb 22, 2024
Insider Transaction Report
Form 4
Habig Scott Michael
Chief Commercial Officer
Transactions
- Award
Common Stock
2024-02-20+195,512→ 508,231 total - Sale
Common Stock
2024-02-20$5.48/sh−15,867$86,951→ 492,364 total
Footnotes (2)
- [F1]Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date.
- [F2]Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs granted on August 1, 2022 grant.